. Rubbery, firm, non-mobile nodule, 1.0×1.0 cm in diameter, on the upper lip with normal overlying labial mucosa and skin.
CASE REPORT
Dermatofibroma (DF) is a common benign mesenchymal tumor composed of fibroblastic and histiocytic cells. It occurs anywhere on the body surface but has a propensity for the extremities. To our knowledge, DF arising in the oral cavity, especially on the lip, is quite rare. DFs of the head and neck region have been known to be most often of the cellular type and frequently recur, so a wider initial excision is recommended. Herein we report a case of DF in a 41-year-old female who presented with a deep-seated nodule on her upper lip. 
INTRODUCTION
Dermatofibroma (DF), also known as benign fibrous histiocytoma (BFH), is a common benign mesenchymal tumor composed of fibroblastic and histiocytic cells 1 . DF occurs anywhere on the body surface but has a propensity for the extremities. To our knowledge, DF arising in the oral cavity or perioral region is quite rare, and its long-term clinical behavior has yet to be elucidated. Herein we reported the clinical, microscopic, and immunohistochemical aspects of a case of DF of the upper lip.
CASE REPORT
A 41-year-old female came to our department for evaluation of a hard nodule on her upper lip that had been noted 4 months earlier. Her medical and family histories were noncontributory. She denied any history of trauma to the lesion. Clinical examination revealed a rubbery, firm, non-mobile nodule, 1.0 cm in diameter, on the upper lip ( Fig. 1 ). The appearance of the overlying labial mucosa and skin was normal. There was no pain or tenderness. Excision biopsy was performed, and the specimen was stained with hematoxylin-eosin. Microscopically, a poorly defined, non-encapsulated, nodular tumor was observed throughout the depth of the dermis. Histological findings showed acanthosis of the epidermis and a poorly defined, non-encapsulated deep dermal tumor ( Fig. 2A ) composed of fibroblastic spindle cells without atypia and pleomorphism in a storiform pattern, separating the dermal collagen, with a few histiocytes in both the superficial ( Fig. 2B ) and deep portions of the tumor (Fig. 2C ). Immunohistochemical stains for CD34, factor XIIIa, CD68 and smooth muscle actin (SMA) were then performed on sections of the tumor. CD34 was negative in fibroblastic spindle tumor cells and positive in vessels (Fig. 3A) , factor XIIIa was positive in only a few dendritic cells and negative in fibroblastic cells (Fig. 3B ), CD68 was weak in spindle cells and strong in histiocytes (Fig. 3C) , and SMA was strong in fibroblastic spindle cells (Fig. 3D) . As a result of clinical and pathologic findings, the diagnosis was interpreted as DF.
DISCUSSION
DF is a common benign dermal fibrohistiocytic tumor that presents as a firm, red-brown nodule. Histologically, the epidermis demonstrates hyperplasia, hyperpigmentation of the basal layer, and elongation of the rete ridges ("dirty fingernail" sign), which are separated by a clear (Grenz) zone from the tumor in the dermis. The tumor itself is composed of fibroblast-like spindle cells, histiocytes, and blood vessels in varying portions. DF has a variable immunohistochemical profile. Early lesions are highly reactive for macrophage markers such as CD68 8 . Most cells in early phase DFs have been found to react with factor XIIIa, a marker of normal dermal dendrocytes. This reactivity is mostly seen at the periphery of the tumor, continuously diminishes with aging of the lesion, and is completely absent in atrophic variants 9 .
Other variably expressed markers include smooth muscle actin, CD56, and NSE. Labeling for SMA is most prominently seen in myofibroblastic DF 10 Paradoxically, cellular atypia is often more pronounced in cellular fibrous histiocytoma than in DFSP, and factor XIIIa staining is often negative. DFs arising on the face, including the oral cavity, are more often of the cellular type, extend into the subcutaneous fat or muscle, and frequently recur 12 . Therefore, a wider initial excision is recommended, and local excision is the definitive treatment for DF of the head and neck region. Because oral DFs are rare and the long-term clinical behavior has yet to be elucidated, regular clinical follow-up is recommended.
